Secondary Logo

Journal Logo

Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naïve HIV-1 Infected Adults with Transmitted Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance Mutations

Wong, Alexander MD1; Goldstein, Deborah MD2; Mallolas, Josep MD, PhD3; DeJesus, Edwin MD4; Johnson, Margaret MD5; Molina, Jean-Michel MD6; Pozniak, Anton MD7; Rodgers, Anthony MS8; Teal, Valerie MS8; Hepler, Deborah BS8; Kumar, Sushma PhD8; Sklar, Peter MD8; Hanna, George J MD8; Hwang, Carey MD, PhD8; Badshah, Cyrus MD, PhD8; Teppler, Hedy MD*,8

JAIDS Journal of Acquired Immune Deficiency Syndromes: August 16, 2019 - Volume Publish Ahead of Print - Issue - p
doi: 10.1097/QAI.0000000000002153
Letters to the Editor: PDF Only

1Department of Medicine, University of Saskatchewan, Regina, Canada

2Whitman-Walker Institute, Washington DC, US

3HIV Unit. Infectious Diseases Service. Hospital Clínic. Barcelona, Spain

4Orlando Immunology Center, Orlando, FL

5Ian Charleson Day Centre, London, UK

6University of Paris Diderot, Hôpital Saint-Louis, Paris, France

7Chelsea and Westminster Hospital, London, UK

8Merck & Co., Inc., Kenilworth NJ, USA.

Corresponding author: Hedy Teppler

Conflicts of interest: AR, VT, DH, SK, PS, GJH, CH, CB, and HT are employees of Merck & Co., Inc., Kenilworth, NJ, USA, and may own stock and/or hold stock options in the Company. JM has received honoraria from Gilead Sciences, Inc, Foster City, CA, and Merck, Sharp, & Dohme Corp, a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA for participating to advisory boards and has received a research grant from Gilead Sciences, Inc.

Source of Funding: Merck, Sharp, & Dohme Corp, a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, provided financial support for the study.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.